Treatment Resistant Disorders
9
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
rTMS Effect on Cognitive and Psychiatric Dysfunction in Patients With Fibromyalgia
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)
Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma
Adding L-carnitine in Clomiphene Resistant Polycystic Ovary Improves the Quality of Ovulation and the Pregnancy Outcome